140 related articles for article (PubMed ID: 21696987)
21. rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial.
Ley D; Hallberg B; Hansen-Pupp I; Dani C; Ramenghi LA; Marlow N; Beardsall K; Bhatti F; Dunger D; Higginson JD; Mahaveer A; Mezu-Ndubuisi OJ; Reynolds P; Giannantonio C; van Weissenbruch M; Barton N; Tocoian A; Hamdani M; Jochim E; Mangili A; Chung JK; Turner MA; Smith LEH; Hellström A;
J Pediatr; 2019 Mar; 206():56-65.e8. PubMed ID: 30471715
[TBL] [Abstract][Full Text] [Related]
22. Characterization of choroid plexus in the preterm rabbit pup following subcutaneous administration of recombinant human IGF-1/IGFBP-3.
Ortenlöf N; Vallius S; Karlsson H; Ekström C; Kristiansson A; Holmqvist B; Göransson O; Vaváková M; Rydén M; Carey G; Barton N; Ley D; Gram M
Fluids Barriers CNS; 2023 Aug; 20(1):59. PubMed ID: 37582792
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
25. Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants:
Horsch S; Parodi A; Hallberg B; Malova M; Björkman-Burtscher IM; Hansen-Pupp I; Marlow N; Beardsall K; Dunger D; van Weissenbruch M; Smith LEH; Hamdani M; Mangili A; Barton N; Ramenghi LA; Hellström A; Ley D;
Front Pediatr; 2020; 8():517207. PubMed ID: 33163463
[No Abstract] [Full Text] [Related]
26. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models.
Tsuboi R; Shi CM; Sato C; Cox GN; Ogawa H
J Invest Dermatol; 1995 Feb; 104(2):199-203. PubMed ID: 7530269
[TBL] [Abstract][Full Text] [Related]
27. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
[TBL] [Abstract][Full Text] [Related]
28. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.
Ferry RJ; Cohen P; Levitt Katz LE
Horm Res; 2005; 63(5):220-7. PubMed ID: 15886488
[TBL] [Abstract][Full Text] [Related]
30. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
Regan FM; Williams RM; McDonald A; Umpleby AM; Acerini CL; O'Rahilly S; Hovorka R; Semple RK; Dunger DB
J Clin Endocrinol Metab; 2010 May; 95(5):2113-22. PubMed ID: 20233784
[TBL] [Abstract][Full Text] [Related]
31. The effects of recombinant human insulin-like growth factor-1/insulin-like growth factor binding protein-3 administration on lipid and carbohydrate metabolism in recreational athletes.
Guha N; Nevitt SP; Francis M; Böhning W; Böhning D; Sönksen PH; Holt RIG
Clin Endocrinol (Oxf); 2021 Apr; 94(4):551-562. PubMed ID: 33249593
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
[TBL] [Abstract][Full Text] [Related]
33. Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates.
Salamat-Miller N; Qu W; Chadwick JS; McPherson C; Salinas PA; Turner M; Wang D; Barton N
J Pharm Sci; 2022 May; 111(5):1486-1496. PubMed ID: 34717953
[TBL] [Abstract][Full Text] [Related]
34. Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).
Hanew K; Tanaka A
J Endocrinol Invest; 2001 Jan; 24(1):1-7. PubMed ID: 11227726
[TBL] [Abstract][Full Text] [Related]
35. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
[TBL] [Abstract][Full Text] [Related]
36. Orally administered IGF-I increases intestinal mucosal growth in formula-fed neonatal pigs.
Burrin DG; Wester TJ; Davis TA; Amick S; Heath JP
Am J Physiol; 1996 May; 270(5 Pt 2):R1085-91. PubMed ID: 8928910
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding protein-1 induces insulin release in the rat.
Mortensen DL; Won WB; Siu J; Reifsnyder D; Gironella M; Etcheverry T; Clark RG
Endocrinology; 1997 May; 138(5):2073-80. PubMed ID: 9112407
[TBL] [Abstract][Full Text] [Related]
38. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
40. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
